No significant impact of patient age and prior treatment profile with docetaxel on the efficacy of cabazitaxel in patient with castration-resistant prostate cancer

BACKGROUND: The correlation of the oncological outcomes of docetaxel and cabazitaxel in Japanese metastatic castration-resistant prostate cancer (mCRPC) patients has not been unclear. MATERIALS AND METHODS: This study included a total of 47 consecutive Japanese mCRPC patients treated with cabazitaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosaka, Takeo, Hongo, Hiroshi, Watanabe, Keitaro, Mizuno, Ryuichi, Kikuchi, Eiji, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267665/
https://www.ncbi.nlm.nih.gov/pubmed/30283980
http://dx.doi.org/10.1007/s00280-018-3698-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267665/
https://www.ncbi.nlm.nih.gov/pubmed/30283980
http://dx.doi.org/10.1007/s00280-018-3698-1

Ejemplares similares